About Us

Pioneering Science. Empowering Macrophages. Transforming Lives.

Our Vision

Pioneering macrophage cell therapy for transformative outcomes in inflammatory organ diseases.

Our Focus

Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a complex surgical procedure limited by complications and a shortage of donors. At Resolution, we are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.

What gives Resolution our winning mindset?

Being BOLD. Working as ONE TEAM. With INTEGRITY. 

 

Our core values serve as the driving force behind our actions, shape our behaviors and foster a collaborative, safe and inclusive environment. The belief in our science and in our values allow us to be at the forefront of regenerative medicine, striving to deliver to patients the first autologous anti-inflammatory and anti-fibrotic macrophage cell therapy for inflammatory organ diseases. 

Management Team

Picture of Alex Armesilla
Alex Armesilla
Senior Director, Cell Engineering
Picture of Chris Baldwin
Chris Baldwin
VP, Manufacturing & Supply
Picture of Cliff Brass, MD PhD FAASLD
Cliff Brass, MD PhD FAASLD
Chief Medical Officer
Picture of Lara Campana
Lara Campana
VP, Research Operations
Picture of Victor Dillard
Victor Dillard
VP, Strategy & Operations
Picture of Eli Gilsohn
Eli Gilsohn
VP, Intellectual Property
Picture of Amir Hefni
Amir Hefni
CEO
Picture of Steven Howe
Steven Howe
VP, Process Development
Picture of Amol Ketkar
Amol Ketkar
Chief Manufacturing and Technical Operations Officer
Picture of Esther Kitto
Esther Kitto
VP, Clinical Operations
Picture of Anna-Kaisa Lehtivarjo
Anna-Kaisa Lehtivarjo
Senior Director, Head of Quality
Picture of Damian Marshall
Damian Marshall
VP, Analytical Development
Picture of Sarah McCrory
Sarah McCrory
Senior Director, Project Management
Picture of Shazia Rahman
Shazia Rahman
VP, People & Culture
Picture of Simon Ramsden
Simon Ramsden
Chief Financial Officer
Picture of Philip Starkey Lewis
Philip Starkey Lewis
Principal Scientist

The Founders

Picture of Prof. Stuart Forbes
Prof. Stuart Forbes
Prof. of Transplantation & Regenerative Medicine - University of Edinburgh
Picture of Prof. John Campbell
Prof. John Campbell
Director - TCAT Scottish National Blood Transfusion Service

The Board of Directors

Picture of Lisa Bright
Lisa Bright
Chair
Picture of Simon Durrant
Simon Durrant
Investment Executive - Old College Capital, University of Edinburgh (Observer)
Picture of Prof. Stuart Forbes
Prof. Stuart Forbes
Prof. of Transplantation & Regenerative Medicine - University of Edinburgh
Picture of Gonzalo Garcia
Gonzalo Garcia
Partner - Syncona (Observer)
Picture of Amir Hefni
Amir Hefni
CEO - Resolution Therapeutics
Picture of Edward Hodgkin
Edward Hodgkin
Managing Partner - Syncona
Picture of Bill Symonds
Bill Symonds
Non-Executive Director